MAPT and depressive symptom measurement: For example, individuals that exhibit early anxiety or depression show greater amyloid-β accumulation, hippocampal atrophy, and tau pathology, thus suggesting that NPS may not simply be reactive symptoms, but instead reflect early disease mechanisms that are driving both behavioral and cognitive changes.